Market Analysis
Product Positioning
Competitor Monitoring
Find Global Buyers
Find Contact Information
Company Comparison
Supply Chain Optimization
Email Marketing
Customer Management
Blog
FAQs
About Topease
Agency Program
United StatesCareFusion 213 LLC is a wholly-owned subsidiary of Becton, Dickinson and Company (BD), registered in the United States. It operates a drug and medical device manufacturing facility at 1550 Northwestern Drive in El Paso, Texas, which produces sterile drug products including antiseptic skin preparations such as the BD PurPrep povidone-iodine solution. The facility falls under BD's parent organization and is subject to FDA regulation for human drugs and medical devices, including GMP inspections and warning letters. The entity traces to the broader CareFusion business, which originated in 2009 as a spinoff of Cardinal Health's medical technology operations and was acquired by BD in 2015. The specific incorporation date of the CareFusion 213 LLC legal entity itself is not publicly documented.
| Import | Export |
|---|---|
|
Trade Records
1011
|
Trade Records
39
|
|
Suppliers
4
|
Buyers
3
|
|
Latest Import Date
2026-07
|
Latest Export Date
2026-06
|
According to Topease's global trade data, CAREFUSION 213 LLC exports products to verified importers across global markets.
Its export activity is associated with HS-code categories such as:
Representative importers include:
These export insights help users understand the CAREFUSION 213 LLC distribution footprint, product specialization, and shipment scale. Through Topease's deep trade data and trade intelligence capabilities—such as trade flow analysis and market benchmarking—importers and exporters can evaluate downstream demand and identify potential importer relationships.
As an importer, CAREFUSION 213 LLC sources products from verified exporters across multiple regions.
Its import activity spans HS-code categories including:
Representative exporters include:
These import insights help users assess sourcing patterns, supplier concentration, and trade continuity. With Topease's analytical tools—such as sourcing pattern analysis and supply-chain mapping—users can evaluate supplier performance and identify diversification opportunities.
Explore CAREFUSION 213 LLC's import activity, including trade volumes, top suppliers, sourcing countries, and key product categories. These insights allow exporters and potential suppliers to understand its global supply chains, track procurement trends, and identify new business opportunities.
| Exporter | Importer | HS Code | Number of Trade | Amount (USD) | Quantity | Import Port |
|---|---|---|---|---|---|---|
| BECTON DICKINSON DE MEXICO S.A. DE C.V. | CAREFUSION 213 LLC | 3923 | 24 | $186,500 | 3,420 | Los Angeles |
| WESTROCK GRAPHICS INC. | CAREFUSION 213 LLC | 4819 | 24 | $186,500 | 3,420 | Los Angeles |
| MEDICHEM SA | CAREFUSION 213 LLC | — | 24 | $186,500 | 3,420 | Los Angeles |
| PANASONIC CORPORATION | CAREFUSION 213 LLC | — | 24 | $186,500 | 3,420 | Los Angeles |
Gain insights into CAREFUSION 213 LLC's export activities, including shipment volumes, key buyers, destination countries, and product categories. Understand global demand patterns, track sales reach, and spot opportunities to connect with potential buyers.
| Importer | Exporter | HS Code | Number of Trade | Amount (USD) | Quantity | Export Port |
|---|---|---|---|---|---|---|
| BECTON DICKINSON DE MEXICO S.A. DE C.V. | CAREFUSION 213 LLC | 3005 | 24 | $186,500 | 3,420 | Los Angeles |
| MED LATINOAMERICA S.A. | CAREFUSION 213 LLC | 3005 | 24 | $186,500 | 3,420 | Los Angeles |
| GERRESHEIMER QUERETARO SA | CAREFUSION 213 LLC | 3923 | 24 | $186,500 | 3,420 | Los Angeles |
Chain Insights — Explore CAREFUSION 213 LLC's trading network to uncover connections with international buyers and suppliers. With Topease's Supply Chain Solution, you can track product flows and identify patterns that reveal new sourcing and partnership opportunities.
Access CAREFUSION 213 LLC's key professional contacts for B2B outreach purposes. View verified phone numbers, emails, and LinkedIn profiles to facilitate efficient business communication.
Disclaimer: Data is compiled from public and third-party sources and may not be complete or fully accurate. This information is provided for business intelligence purposes only and should not be used for legal, financial, or compliance decisions.